WO2005108392A3 - Process for preparing ondansetron hydrochloride dihydrate having a defined particle size - Google Patents
Process for preparing ondansetron hydrochloride dihydrate having a defined particle size Download PDFInfo
- Publication number
- WO2005108392A3 WO2005108392A3 PCT/IL2005/000473 IL2005000473W WO2005108392A3 WO 2005108392 A3 WO2005108392 A3 WO 2005108392A3 IL 2005000473 W IL2005000473 W IL 2005000473W WO 2005108392 A3 WO2005108392 A3 WO 2005108392A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- ondansetron hydrochloride
- particle size
- hydrochloride dihydrate
- preparing
- defined particle
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Abstract
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002565854A CA2565854A1 (en) | 2004-05-07 | 2005-05-05 | Process for preparing ondansetron hydrochloride dihydrate having a defined particle size |
IL179086A IL179086A0 (en) | 2004-05-07 | 2006-11-06 | Process for preparing ondansetron hydrochloride dihydrate having a defined particle size |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US56899204P | 2004-05-07 | 2004-05-07 | |
US60/568,992 | 2004-05-07 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2005108392A2 WO2005108392A2 (en) | 2005-11-17 |
WO2005108392A3 true WO2005108392A3 (en) | 2006-02-09 |
Family
ID=35320786
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IL2005/000473 WO2005108392A2 (en) | 2004-05-07 | 2005-05-05 | Process for preparing ondansetron hydrochloride dihydrate having a defined particle size |
Country Status (3)
Country | Link |
---|---|
US (1) | US7288660B2 (en) |
CA (1) | CA2565854A1 (en) |
WO (1) | WO2005108392A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7696356B2 (en) * | 2004-08-17 | 2010-04-13 | Taro Pharmaceutical Industries Limited | Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-methylene-4H-carbazol-4-one and ondansetron therefrom |
CN110857474B (en) * | 2018-08-24 | 2023-04-18 | 武汉远大弘元股份有限公司 | Method for treating L-cysteine hydrochloride monohydrate |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4695578A (en) * | 1984-01-25 | 1987-09-22 | Glaxo Group Limited | 1,2,3,9-tetrahydro-3-imidazol-1-ylmethyl-4H-carbazol-4-ones, composition containing them, and method of using them to treat neuronal 5HT function disturbances |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AT392276B (en) | 1984-01-25 | 1991-02-25 | Glaxo Group Ltd | METHOD FOR PRODUCING NEW TETRAHYDROCARBAZOL DERIVATIVES |
US4826689A (en) | 1984-05-21 | 1989-05-02 | University Of Rochester | Method for making uniformly sized particles from water-insoluble organic compounds |
GB8516083D0 (en) | 1985-06-25 | 1985-07-31 | Glaxo Group Ltd | Heterocyclic compounds |
FR2608988B1 (en) | 1986-12-31 | 1991-01-11 | Centre Nat Rech Scient | PROCESS FOR THE PREPARATION OF COLLOIDAL DISPERSIBLE SYSTEMS OF A SUBSTANCE, IN THE FORM OF NANOPARTICLES |
GB8805269D0 (en) | 1988-03-04 | 1988-04-07 | Glaxo Group Ltd | Medicaments |
GB8914804D0 (en) | 1989-06-28 | 1989-08-16 | Glaxo Group Ltd | Process |
US20020115707A1 (en) | 2001-01-11 | 2002-08-22 | Rami Lidor-Hadas | Process for preparing pure ondansetron hydrochloride dihydrate |
MXPA04010845A (en) | 2002-04-30 | 2005-01-25 | Biogal Gyogyszergyar | Novel crystal forms of ondansetron, processes for their preparation, pharmaceutical compositions containing the novel forms and methods for treating nausea using them. |
HU225885B1 (en) | 2002-10-17 | 2007-11-28 | Richter Gedeon Nyrt | Process for producing ondansetron hydrochlorid dihydrate of high purity |
FI6164U1 (en) | 2003-01-09 | 2004-03-15 | Synthon Bv | Ondansetronformer |
-
2005
- 2005-05-05 CA CA002565854A patent/CA2565854A1/en not_active Abandoned
- 2005-05-05 US US11/122,401 patent/US7288660B2/en not_active Expired - Fee Related
- 2005-05-05 WO PCT/IL2005/000473 patent/WO2005108392A2/en active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4695578A (en) * | 1984-01-25 | 1987-09-22 | Glaxo Group Limited | 1,2,3,9-tetrahydro-3-imidazol-1-ylmethyl-4H-carbazol-4-ones, composition containing them, and method of using them to treat neuronal 5HT function disturbances |
Also Published As
Publication number | Publication date |
---|---|
CA2565854A1 (en) | 2005-11-17 |
US7288660B2 (en) | 2007-10-30 |
US20050261351A1 (en) | 2005-11-24 |
WO2005108392A2 (en) | 2005-11-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2003093269A3 (en) | Substituted pyrazolo-pyrimidine-4-ones | |
AU2003233010A1 (en) | Process for the preparation of 3,3,4,4-tetrafluoropyrrolidine and derivatives thereof | |
HK1098737A1 (en) | Process for the preparation of 1,1,1,3,3-pentafluoro-2-chloropropene and 1,1,1,3,3,3-hexafluoro-2-chloropropane | |
AU2002310868A1 (en) | Method for the production of biologically-degradable packagings made from biaxially-drawn films | |
AU2003221270A1 (en) | Nanocomposites: products, process for obtaining them and uses thereof | |
AU2003280711A1 (en) | Titania-metal composite and method for preparation thereof, and film forming method using dispersion comprising the composite | |
WO2004062892A3 (en) | Methods and systems for producing an object through solid freeform fabrication | |
AU2003246159A1 (en) | Nobonene-ester based addition polymer and method for preparing the same | |
AU2003268694A1 (en) | Method of processing formed product, and metal cope and metal drag used for the method | |
AU2002356513A1 (en) | Triazine compounds polymers comprising triazine structural units, and processes for the preparation of these polymers | |
AU2003258669A1 (en) | Highly stable polymer dispersions and method for the production thereof | |
AU2003288335A1 (en) | Nanometric or mesoscopic dissymetric particles, and method for preparing same | |
AU2003270109A1 (en) | Stable polymer dispersions and method for the production thereof | |
WO2005108392A3 (en) | Process for preparing ondansetron hydrochloride dihydrate having a defined particle size | |
AU2003235114A1 (en) | Stress inhibition composition, theanine-containing granule and process for producing the same | |
WO2005023215A3 (en) | Particles shaped as platelets | |
AU2003264016A1 (en) | High density composition of matter, articles made therefrom, and processes for the preparation thereof | |
WO2004078142A3 (en) | Compositions and methods for preventing and treating endotoxin-related diseases and conditions | |
WO2006129125A3 (en) | Improvements relating to respiratory apparatus | |
WO2004030469A3 (en) | Gelling composition | |
AU2003214140A1 (en) | Process for the production of melamine from urea, and particularly for the separation of melamine from off-gas | |
AU2003238342A1 (en) | Nanocomposites based on polyolefin, method for the production thereof, and use of the same | |
AU2003292099A1 (en) | Iron-nickel-cobalt alloy, method for the production and use thereof | |
AU2003300559A1 (en) | Agglomerated gelatin powder and method for the production thereof | |
AU2003269001A1 (en) | Derivatives of uronic (alkyl-d-mannopyranoside) acid, methods for the preparation thereof, and applications thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2565854 Country of ref document: CA Ref document number: 179086 Country of ref document: IL |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: DE |
|
122 | Ep: pct application non-entry in european phase |